Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:46 PM
Ignite Modification Date:
2025-12-24 @ 10:46 PM
NCT ID:
NCT04802369
Eligibility Criteria:
Inclusion Criteria:
* Age equal to or older than 40 years
* Arterial hypertension (HA) diagnosed according to the 2018 European Society of Cardiology (ESC) guidelines of HA \[1\]
* Current HA hospitalization
Exclusion Criteria:
* Severe hypertension
* Diagnosis of heart failure or typical symptomatic heart failure
* Left ventricular ejection fraction (LVEF) \<50%
* Documented: hyperandrogenism, hyperestrogenism, insulin resistance, premature ovarian failure, polycystic ovary syndrome
* Past myocardial infarction
* Diagnosis of cardiomyopathy (hypertrophic, dilated, restrictive, peripartum, arrhythmogenic)
* Lysosomal storage disorders
* Stroke, transient ischemic attack, Intracerebral hemorrhage in medical history
* Severe hyper- and hypothyroidism
* Pregnancy and lactation
* Chronic kidney disease (IV, V stadium according to National Kidney Foundation) and dialysis treatment
* Documented neoplastic process
* The patient's inability to cooperate and/or provide informed consent to participate in a research
* Alcohol and drug abuse
* Active autoimmune disease
* Treatment using immunosuppressants, cytostatic drugs, glucocorticosteroids, or antiretroviral drugs
* A history of bone marrow transplant or other organ transplant, treatment with blood products within the last 6 months
* Active systemic infection
* Hepatitis B virus (HBV), hepatitis C virus (HCV) or human immunodeficiency virus (HIV) carrier or positive for hepatitis B surface antigen (HBSAg) or antibodies to HCV
* Surgery or serious injury within the last month
* Patients who did not express their informed consent to participate in the study
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
40 Years
Maximum Age:
99 Years
Study:
NCT04802369
Study Brief:
Protocol Section:
NCT04802369